203 top medical experts on Farber Lipogranulomatosis across 26 countries and 14 U.S. states, including 29 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Farber Lipogranulomatosis: A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of ceramides in various tissues due to an inherited deficiency of acid ceramidase.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Sphingolipidoses (136).
  4. Clinical Trials ClinicalTrials.gov : at least 2 including 1 Active, 1 Completed


  

        

                    


    Computing Expert Listing ...

);